News - Latest
37 news items
Sort by: Date / Relevance
Request to take over the pyridoxine hydrochloride marketing authorisation
The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...
Changes to product information policy
The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...
Coronavirus - MEB employees work from home
Complying with the Dutch government guidelines regarding the coronavirus situation, MEB employees will be working from home as of ...
Regulatory Science Magazine 10: Reduction, replacement and refinement of animal studies
This week, the newest edition of the Regulatory Science Magazine was issued. This 10th edition of the online science magazine of ...
Amended policy on DHPCs
The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...
MEB confirms current legal status of supply ibuprofen 200 mg
The Medicines Evaluation Board (MEB) has evaluated whether the recent European review of the adverse events on heart and blood ...
Decision regarding the Brinzolamide objection
The Medicines Evaluation Board (MEB) has made a decision regarding an objection by Alcon Laboratories (UK) Ltd.